Safety and disease response to MEDI-551, an anti-CD19 antibody, in chronic lymphocytic leukemia patients previously treated with rituximab. (7th November 2013) - Forero, Andres; Hamadani, Mehdi; Kipps, Thomas; Fanale, Michelle; Cuneo, Antonio; Perez de Oteyza, Jaime; Gladstone, Douglas; Andre, Marc; Bellam, Naresh; Goswami, Trishna; Ibrahim, Ramy; Schneider, Amy; et al.